ABOUT US
Tune In to Hep C, a public health campaign created to raise awareness of chronic hepatitis C virus (HCV) infection, adds a new voice to the chorus. Jon Secada, three-time GRAMMY® award-winning Cuban-American recording artist and songwriter, hopes that sharing his family's personal experience through this bilingual awareness campaign will motivate Hispanic Americans with chronic HCV to take action and speak to their doctors about their options.
Secada revealed for the first time that his father recently passed away from complications associated with chronic HCV infection, a disease that disproportionately affects the Hispanic community. In fact, of the nearly 3.2 million Americans who have chronic HCV, an estimated one million are Hispanic.
"My father chose not to tell anyone about his disease for a long time, and he chose not to take action against it for reasons I may never understand. Before he passed away, he told me that he wanted me to share his story to help other people like him who have chronic hepatitis C but aren't taking action," said Secada, who was unaware of his father's diagnosis for more than a decade. "You can't be silent with a silent disease that has consequences like chronic hepatitis C - you need to talk to your doctor and talk to your family."
Secada joins Merck, the American Liver Foundation (ALF) and fellow GRAMMY® winners Gregg Allman of The Allman Brothers Band and Natalie Cole on the Tune In to Hep C initiative, which Merck and ALF launched last year.
Read more about this campaign and the potential risk factors of chronic hepatitis C.
Congratulations to Gregg Allman on the success of his album "Low Country Blues," which recently brought him another GRAMMY® nomination, and for showing, once again, that in the face of adversity, doing nothing is not an option.
Read Gregg's story.